Takeda Offered 600 M. Yen in Grants to Kyoto University Involved in CASE-J Study, Where Ex-Employee Affiliated

Takeda Pharmaceutical had extended research grants totaling 600 million yen to Kyoto University’s EBM Research Center, which performed data analyses of a large-scale clinical study on its angiotensin receptor blocker Blopress (candesartan), it was learned on December 4. The grants...read more